New report adds to growing evidence of iNKT cell therapy’s potential in solid tumorsNEW YORK, July 11, 2025 (GLOBE NEWSWIRE) ...

The instinct to protect and secure a child’s future—especially when it comes to their health—is one of the deepest and most ...

MiNK Therapeutics shares jumped as new clinical data show durable remission in testicular cancer and tumor reduction in ...

MiNK Therapeutics surged on tumor remission data for agenT-797, but financial risks and limited clinical proof remain. Learn ...

Even a little movement goes a long way. As Dr. George explains, just 75 minutes of activity a week, that’s about 11 minutes a ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

By Bunmi Sofola Recently scientific research has shown the risk of having heart failure or a stroke doubles in the first ...

In an interview with Moneycontrol on July 14, Glenn Saldanha, Chairman and Managing Director of Glenmark, discussed the ...

Shares of MiNK Therapeutics, Inc. (INKT) skyrocketed on Friday following the publication of a case from its clinical trial ...

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...

We've all heard of retinol at this point, but there are so many different options available on the market - shoppers are ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...